相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
Graca M. Dores et al.
BLOOD (2012)
Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data
Reshma Jagsi et al.
CANCER (2012)
Underreporting of Myeloid Malignancies by United States Cancer Registries
Benjamin M. Craig et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Treatment advances have not improved the early death rate in acute promyelocytic leukemia
James Scott McClellan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Blood, sex and tears: speculations on the gender imbalance in hematologic malignancies
Janette van den Berghe et al.
LEUKEMIA & LYMPHOMA (2012)
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Todd A. Fehniger et al.
BLOOD (2011)
Most 70-to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment
Gunnar Juliusson
BLOOD (2011)
Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting
Kristjan Paulson et al.
BLOOD (2011)
Applicability of a Pick a Winner trial design to acute myeloid leukemia
Robert K. Hills et al.
BLOOD (2011)
Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples
Marie-Chantal Ethier et al.
BLOOD (2011)
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
Jae H. Park et al.
BLOOD (2011)
The EBMT activity survey 2008: impact of team size, team density and new trends
A. Gratwohl et al.
BONE MARROW TRANSPLANTATION (2011)
Deciphering Surveillance, Epidemiology, and End Results Data Analysis Are We Seeing the Whole Picture?
Kate E. Oliver et al.
CANCER (2011)
Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006
Gunnar Juliusson et al.
CANCER (2011)
Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry
Gunnar Juliusson
Clinical Lymphoma Myeloma & Leukemia (2011)
Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
Alan K. Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Modern Approaches to Treating Acute Promyelocytic Leukemia
Miguel A. Sanz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
S. Lehmann et al.
LEUKEMIA (2011)
Geographic Variation in Physicians' Responses to a Reimbursement Change
Mireille Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Population-based analyses in adult acute lymphoblastic leukemia
Gunnar Juliusson et al.
BLOOD (2010)
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm
Roland B. Walter et al.
BLOOD (2010)
Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia
Caroline M. Bateman et al.
BLOOD (2010)
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
Hagop Kantarjian et al.
BLOOD (2010)
Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study
Fatima Bhayat et al.
BMC CANCER (2010)
Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial
Alan K. Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Population genetics meets cancer genomics
Roland R. Regoes
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
Asa Rangert Derolf et al.
BLOOD (2009)
The incidence of and mortality from leukaemias in the UK: a general population-based study
Fatima Bhayat et al.
BMC CANCER (2009)
Do commonly used clinical trial designs reflect clinical reality?
Elihu Estey
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Anthracycline Dose Intensification in Acute Myeloid Leukemia
Hugo F. Fernandez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment of Adult Acute Lymphoblastic Leukemia
Nicola Goekbuget et al.
SEMINARS IN HEMATOLOGY (2009)
Variation in Supportive Care Practices in Hematopoietic Cell Transplantation
Stephanie J. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
Arcangelo Liso et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Relevance of clinical trials in acute myeloid leukaemia
Apostolia M. Tsimberidou et al.
HEMATOLOGICAL ONCOLOGY (2008)
Mathematical models of cancer stem cells
Franziska Michor
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003
Ingemar Turesson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
Alan K. Burnett et al.
CANCER (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Interpreting trends in cancer patient survival
P. W. Dickman et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival
G Juliusson et al.
LEUKEMIA (2006)
Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population
M Åström et al.
LEUKEMIA & LYMPHOMA (2001)
分享论文
